Abstract:α-Conotoxins potently inhibit isoforms of nicotinic acetylcholine receptors (nAChRs), which are essential for neuronal and neuromuscular transmission. They are also used as neurochemical tools to study nAChR physiology and are being evaluated as drug leads to treat various neuronal disorders. A number of experimental studies have been performed to investigate the structure-activity relationships of conotoxin/nAChR complexes. However, the structural determinants of their binding interactions are still ambiguous in the absence of experimental structures of conotoxin-receptor complexes. In this study, the binding modes of α-conotoxin ImI to the α7-nAChR, currently the best-studied system experimentally, were investigated using comparative modeling and molecular dynamics simulations. The structures of more than 30 single point mutants of either the conotoxin or the receptor were modeled and analyzed. The models were used to explain qualitatively the change of affinities measured experimentally, including some nAChR positions located outside the binding site. Mutational energies were calculated using different methods that combine a conformational refinement procedure (minimization with a distance dependent dielectric constant or explicit water, or molecular dynamics using five restraint strategies) and a binding energy function (MM-GB/SA or MM-PB/SA). The protocol using explicit water energy minimization and MM-GB/SA gave the best correlations with experimental binding affinities, with an R2 value of 0.74. The van der Waals and non-polar desolvation components were found to be the main driving force for binding of the conotoxin to the nAChR. The electrostatic component was responsible for the selectivity of the various ImI mutants. Overall, this study provides novel insights into the binding mechanism of α-conotoxins to nAChRs and the methodological developments reported here open avenues for computational scanning studies of a rapidly expanding range of wild-type and chemically modified α-conotoxins.

Delineation of the Unbinding Pathway of Α-Conotoxin ImI from the Α7 Nicotinic Acetylcholine Receptor.

Blockade of Neuronal Α7-Nachr by Α-Conotoxin ImI Explained by Computational Scanning and Energy Calculations

Investigation of α-conotoxin unbinding using umbrella sampling.

Computational determination of the binding mode of α-conotoxin to nicotinic acetylcholine receptor

Diverse toxins exhibit a common binding mode to the Nicotinic Acetylcholine Receptors revealing a new molecular determinant

Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.

Antagonistic Mechanism of alpha-Conotoxin BuIA toward the Human alpha 3 beta 2 Nicotinic Acetylcholine Receptor

Atypical Α-Conotoxin LtIA from Conus Litteratus Targets a Novel Microsite of the Α3β2 Nicotinic Receptor

Blockade of Human α7 Nicotinic Acetylcholine Receptor by α-Conotoxin ImI Dendrimer: Insight from Computational Simulations.

Interaction of Rat Α9α10 Nicotinic Acetylcholine Receptor with Α-Conotoxin RgIA and Vc1.1: Insights from Docking, Molecular Dynamics and Binding Free Energy Contributions

Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.

Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.

Computational Design of α-Conotoxins to Target Specific Nicotinic Acetylcholine Receptor Subtypes

Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.

Mechanism of Action and Structure-Activity Relationship of a-Conotoxin Mr1.1 at the Human a9a10 Nicotinic Acetylcholine Receptor

Α-Conotoxin [s9a]txid Potently Discriminates Between Α3β4 and Α6/α3β4 Nicotinic Acetylcholine Receptors

Mechanism of Interactions Between Α-Conotoxin RegIIA and Carbohydrates at the Human Α3β4 Nicotinic Acetylcholine Receptor

Alpha-Conotoxins Active At Alpha 3-Containing Nicotinic Acetylcholine Receptors And Their Molecular Determinants For Selective Inhibition

Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.

Synthesis and characterization of αM-conotoxin SIIID, a reversible human α7 nicotinic acetylcholine receptor antagonist

Dimerization of alpha-Conotoxins as a Strategy to Enhance the Inhibition of the Human alpha 7 and alpha 9 alpha 10 Nicotinic Acetylcholine Receptors